Live Breaking News & Updates on Exevir

Stay updated with breaking news from Exevir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

/PRNewswire/ ExeVir is developing robust therapies providing broad protection against infectious diseases, including coronaviruses. The company has. ....

Jeanne Bolger , Exevir Bio , Prnewswire Exevir , Torsten Mummenbrauer , Royal Academy Of Medicine Ireland , European Union , Trinity College Dublin , University College Dublin , Business Development , Venture Investments , Johnson Innovation , Venture Partner , Seroba Life Sciences Venture Capital , Pharmaceutical Medicine , Trinity College , University College , Royal Academy , Vir Bio , V Bio Ventures ,

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing
- Extends Series A with additional EUR19 million led by Fund+
- Unique llama-derived VHH72-Fc antibody (XVR011) for potential treatment and prevention of Covid-19, ready to start first-in-human trials
- XVR011 expected to be effective against SARS-Cov-2 and importantly its rapidly spreading variants and other Sarbecoviruses to emerge in the future
News provided by
Share this article
Share this article
GHENT, Belgium, March 16, 2021 /PRNewswire/ ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has closed its Series A financing raising a total of EUR 42 million / US$50 million. The financing was led by Fund+ with VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures and new investors SRIW, Noshaq, Vives IUF, SambrInvest, as well as several Belgian family offices. ....

France General , Waals Gewest , Region Flamande , Louvain La Neuve , Bruxelles Capitale , Michel Kazatchkine , Xavier Saelens , Prnewswire Exevir , Erica Whittaker , Caroline Thielen , Van Biervliet , Katja Rosenkranz , Exevir Bio , Torsten Mummenbrauer , Philippe Monteyne , Stef Heylen , Nico Callewaert , Investissement Federale Participatie , Belgian Federal Holding , European Life Sciences , Partner At Fund , Hasselt University , Ghent University , University Of Li , University Fund , Life Sciences ,

ExeVir Bio Announces New Publication from VIB Scientists Showing Potent and Broad Neutralizing Activity and Infection Protection Against SARS-COV, its Variants of Concern and Related Coronaviruses

/PRNewswire/ ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, announces the preprint. ....

South Africa , United States , United Kingdom , Xavier Saelens , Exevir Bio , Prnewswire Exevir , Torsten Mummenbrauer , Professorxavier Saelens , Nico Callewaert , Molecular Virology Group Leader , Medical Biotechnology , Scientific Director , Professors Xavier Saelens , Vir Bio , Professor Drs Xavier Saelens , Belgian Family , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , மூலக்கூறு வைராலஜி குழு தலைவர் , மருத்துவ உயிரி தொழில்நுட்பவியல் , அறிவியல் இயக்குனர் , வீர் உயிர் , பெல்ஜியன் குடும்பம் ,